CIBC Asset Management Inc Purchases 23,732 Shares of Xylem Inc. $XYL

CIBC Asset Management Inc lifted its position in shares of Xylem Inc. (NYSE:XYL) by 70.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,608 shares of the industrial products company’s stock after acquiring an additional 23,732 shares during the period. CIBC Asset Management Inc’s holdings in Xylem were worth $7,845,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in XYL. AQR Capital Management LLC increased its position in shares of Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after acquiring an additional 3,900 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Xylem by 3.3% during the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after acquiring an additional 132 shares in the last quarter. Empowered Funds LLC grew its position in Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after purchasing an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock worth $1,442,000 after purchasing an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in Xylem by 114.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after purchasing an additional 635 shares during the period. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 0.3%

Shares of Xylem stock opened at $109.84 on Friday. The company has a market capitalization of $26.11 billion, a P/E ratio of 27.32, a P/E/G ratio of 1.57 and a beta of 1.04. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a fifty day moving average of $116.75 and a 200 day moving average of $128.41. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. The company had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. Xylem’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem’s dividend payout ratio is currently 42.79%.

Xylem declared that its board has approved a stock repurchase plan on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the industrial products company to reacquire up to 4.8% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its shares are undervalued.

Analyst Ratings Changes

Several brokerages recently commented on XYL. JPMorgan Chase & Co. cut their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Barclays reduced their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Jefferies Financial Group reiterated a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research note on Tuesday, March 31st. Royal Bank Of Canada dropped their price objective on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating on the stock in a report on Wednesday, February 11th. Finally, Robert W. Baird set a $161.00 price objective on shares of Xylem in a report on Wednesday, February 11th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $152.77.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.